120 related articles for article (PubMed ID: 16925583)
1. Deletion and single nucleotide substitution at G:C in the kidney of gpt delta transgenic mice after ferric nitrilotriacetate treatment.
Jiang L; Zhong Y; Akatsuka S; Liu YT; Dutta KK; Lee WH; Onuki J; Masumura K; Nohmi T; Toyokuni S
Cancer Sci; 2006 Nov; 97(11):1159-67. PubMed ID: 16925583
[TBL] [Abstract][Full Text] [Related]
2. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate.
Nishiyama Y; Suwa H; Okamoto K; Fukumoto M; Hiai H; Toyokuni S
Jpn J Cancer Res; 1995 Dec; 86(12):1150-8. PubMed ID: 8636003
[TBL] [Abstract][Full Text] [Related]
3. DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate.
Toyokuni S; Mori T; Dizdaroglu M
Int J Cancer; 1994 Apr; 57(1):123-8. PubMed ID: 8150530
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of integrin-associated protein (CD47) in rat kidney treated with a renal carcinogen, ferric nitrilotriacetate.
Nishiyama Y; Tanaka T; Naitoh H; Mori C; Fukumoto M; Hiai H; Toyokuni S
Jpn J Cancer Res; 1997 Feb; 88(2):120-8. PubMed ID: 9119739
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin.
Toyokuni S; Mori T; Hiai H; Dizdaroglu M
Int J Cancer; 1995 Jul; 62(3):309-13. PubMed ID: 7628872
[TBL] [Abstract][Full Text] [Related]
6. Induction of a wide range of C(2-12) aldehydes and C(7-12) acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate.
Toyokuni S; Luo XP; Tanaka T; Uchida K; Hiai H; Lehotay DC
Free Radic Biol Med; 1997; 22(6):1019-27. PubMed ID: 9034241
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress response in iron-induced renal carcinogenesis: acute nephrotoxicity mediates the enhanced expression of glutathione S-transferase Yp isozyme.
Fukuda A; Osawa T; Oda H; Toyokuni S; Satoh K; Uchida K
Arch Biochem Biophys; 1996 May; 329(1):39-46. PubMed ID: 8619633
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis resistance determines high susceptibility of murine A/J strain to iron-induced renal carcinogenesis.
Cheng Z; Akatsuka S; Li GH; Mori K; Takahashi T; Toyokuni S
Cancer Sci; 2022 Jan; 113(1):65-78. PubMed ID: 34699654
[TBL] [Abstract][Full Text] [Related]
9. Renal cysts and associated renal tumours in male ddY mice injected with ferric nitrilotriacetate.
Kondo A; Deguchi J; Okada S
Virchows Arch; 1995; 427(1):91-9. PubMed ID: 7551351
[TBL] [Abstract][Full Text] [Related]
10. Fenton reaction-induced renal carcinogenesis in Mutyh-deficient mice exhibits less chromosomal aberrations than the rat model.
Li GH; Akatsuka S; Chew SH; Jiang L; Nishiyama T; Sakamoto A; Takahashi T; Futakuchi M; Suzuki H; Sakumi K; Nakabeppu Y; Toyokuni S
Pathol Int; 2017 Nov; 67(11):564-574. PubMed ID: 29027306
[TBL] [Abstract][Full Text] [Related]
11. Protection by alpha G-rutin, a water-soluble antioxidant flavonoid, against renal damage in mice treated with ferric nitrilotriacetate.
Shimoi K; Shen B; Toyokuni S; Mochizuki R; Furugori M; Kinae N
Jpn J Cancer Res; 1997 May; 88(5):453-60. PubMed ID: 9247601
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic and mutagenic effects of ferric nitrilotriacetate on L5178Y mouse lymphoma cells.
Toyokuni S; Sagripanti JL; Hitchins VM
Cancer Lett; 1995 Jan; 88(2):157-62. PubMed ID: 7874688
[TBL] [Abstract][Full Text] [Related]
13. Absence of ras mutations and low incidence of p53 mutations in renal cell carcinomas induced by ferric nitrilotriacetate.
Akiyama T; Hamazaki S; Okada S
Jpn J Cancer Res; 1995 Dec; 86(12):1143-9. PubMed ID: 8636002
[TBL] [Abstract][Full Text] [Related]
14. Renal carcinogenesis induced by ferric nitrilotriacetate in mice, and protection from it by Brazilian propolis and artepillin C.
Kimoto T; Koya S; Hino K; Yamamoto Y; Nomura Y; Micallef MJ; Hanaya T; Arai S; Ikeda M; Kurimoto M
Pathol Int; 2000 Sep; 50(9):679-89. PubMed ID: 11012980
[TBL] [Abstract][Full Text] [Related]
15. A newly established GDL1 cell line from gpt delta mice well reflects the in vivo mutation spectra induced by mitomycin C.
Takeiri A; Mishima M; Tanaka K; Shioda A; Harada A; Watanabe K; Masumura K; Nohmi T
Mutat Res; 2006 Oct; 609(1):102-15. PubMed ID: 16916616
[TBL] [Abstract][Full Text] [Related]
16. Prevention by 2-mercaptoethane sulfonate and N-acetylcysteine of renal oxidative damage in rats treated with ferric nitrilotriacetate.
Umemura T; Hasegawa R; Sai-Kato K; Nishikawa A; Furukawa F; Toyokuni S; Uchida K; Inoue T; Kurokawa Y
Jpn J Cancer Res; 1996 Sep; 87(9):882-6. PubMed ID: 8878448
[TBL] [Abstract][Full Text] [Related]
17. DNA single- and double-strand breaks produced by ferric nitrilotriacetate in relation to renal tubular carcinogenesis.
Toyokuni S; Sagripanti JL
Carcinogenesis; 1993 Feb; 14(2):223-7. PubMed ID: 8435863
[TBL] [Abstract][Full Text] [Related]
18. Formation of 8-hydroxydeoxyguanosine (8-OH-dG) in rat kidney DNA after intraperitoneal administration of ferric nitrilotriacetate (Fe-NTA).
Umemura T; Sai K; Takagi A; Hasegawa R; Kurokawa Y
Carcinogenesis; 1990 Feb; 11(2):345-7. PubMed ID: 2302761
[TBL] [Abstract][Full Text] [Related]
19. Nordihydroguairetic acid is a potent inhibitor of ferric-nitrilotriacetate-mediated hepatic and renal toxicity, and renal tumour promotion, in mice.
Ansar S; Iqbal M; Athar M
Carcinogenesis; 1999 Apr; 20(4):599-606. PubMed ID: 10223187
[TBL] [Abstract][Full Text] [Related]
20. Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate.
Li JL; Okada S; Hamazaki S; Ebina Y; Midorikawa O
Cancer Res; 1987 Apr; 47(7):1867-9. PubMed ID: 3815378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
